COMP <GO>
ICCM vs XAIR // REVENUE GROWTH (YOY)
IceCure Medical Ltd. (NASDAQ) VS. Beyond Air Inc. (NASDAQ) • 15-METRIC TALLY: ICCM 2
— XAIR 4
▲ REVENUE GROWTH (YOY) LEADER: XAIR
LAST: $0.96 (-2.13%) • MKT CAP: $3.3M
revenue-growth
2.70%
LAST: $2.31 (-2.12%) • MKT CAP: $3.8M
revenue-growth
107.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ICCM VS. XAIR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ICCM | XAIR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.30% | 3.30% | +33.00 | ICCM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 0.40% | -60.40 | XAIR | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 2.70% | 107.30% | -104.60 | XAIR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 3/9 | +2.00 | ICCM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 18.1 | 39.7 | -21.59 | XAIR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 94.2x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.3M | $3.8M | -$569.3K | XAIR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ICCM REV | XAIR REV | ICCM GROSS % | XAIR GROSS % | ICCM FCF | XAIR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.4M | $7.7M | 36.3% | 3.3% | -$14.6M | -$19.2M |
| FY 2024 | $3.3M | $3.7M | 44.1% | -44.9% | -$12.6M | -$44.1M |
| FY 2023 | $3.2M | $1.2M | — | — | -$12.6M | -$56.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ICCM // BETA —
XAIR // BETA —